CTRI/2023/06/054079尚未招募Unknown
Comparison of growth parameters at 2 years of corrected gestationalage in preterm infants with and without Metabolic Bone Disease : AnObservational Study
AISHWARYA VENUGOPA0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Group 1 - Preterm babies < 32 weeks diagnosed with Metabolic bone disease, now reached 2 years CGA group
- •Group 2 - Preterm babies < 32 weeks without Metabolic bone disease, now reached 2 years CGA group
- •These children will be followed up at the Follow up clinic of SAT hospital, Govt Medical College, Thiruvananthapuram with parental consent for the study.
- •The subjects for this study are the children followed up at 2 years corrected gestation age (+ 1 month), both with and without metabolic bone disease which was obtained from the Department registry maintained for the same. The operational definition used for defining Metabolic Bone Disease was Serum Phosphorus < 4mg/dl and/or Serum Alkaline phosphatase > 800IU/L.
排除标准
- •Significant systemic illness that affects growth such as Chronic kidney disease, chronic liver disease
- •Children diagnosed with skeletal dysplasias
- •Lack of parental consent for the study
研究者
相似试验
已完成
3 期
Growth Retardation In Children With Special Pathological Conditions Or DiseaseEndocrine System DiseasesNCT00163215Pfizer46
尚未招募
不适用
Growth Chart Parameters, Risk FactorsGrowth DisordersNCT05841264Assiut University600
尚未招募
不适用
Measuring bone growth in bony defects caused by periodontal diseases after treating with growth factors found in blood along with artificial bone powder.CTRI/2019/01/017043Rajarajeswari Dental College and Hospital
尚未招募
4 期
Comparing the study between two blood products to form new bone.CTRI/2024/01/061186Dr Angela Johnson
进行中(未招募)
1 期
Validation study for genetic markers for growth hormone treatment in growth hormone deficient and turner syndrome patientsEUCTR2011-000460-10-ESMerck Serono S.A. Geneva461
